x

Nkarta, Inc. (Nasdaq:NKTX)

Health Care/Life Sciences • Biotechnology
CIK 1787400
Company

Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.

Address
1150 Veterans Boulevard
South San Francisco, California 94080
Employees
150
Stock Info
Close
$1.6400
Day Range
1.5700 - 1.6700
52 Week Range
1.5700 - 16.2400
Average volume
1.46M
Short Interest
9.62M (02/14/25)
% of Float Shorted
20.79%
Market Cap
$115.73M
Revenue
N/A
Net Income
-$117.5M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.8730
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Director
George Vratsanos
Chairman
Ali Behbahani
Independent Director
Zach Scheiner
Independent Director
Angela M. Thedinga
Independent Director
Michael Dybbs
Independent Director
Simeon J. George
Independent Director
Leone D. Patterson
SEC filings
DateFormEvent
13 Dec, 2024 SC 13G
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
12 Nov, 2024 SC 13G/A
8 Nov, 2024 SC 13G
7 Nov, 2024 10-Q
7 Nov, 2024 8-K
25 Oct, 2024 SC 13G/A
24 Oct, 2024 SC 13G
23 Aug, 2024 4
16 Aug, 2024 8-K/A
13 Aug, 2024 10-Q
13 Aug, 2024 8-K
31 Jul, 2024 4
31 Jul, 2024 3
31 Jul, 2024 4
18 Jul, 2024 4
16 Jul, 2024 8-K
16 Jul, 2024 144
27 Jun, 2024 8-K
20 Jun, 2024 4
20 Jun, 2024 4
20 Jun, 2024 4
20 Jun, 2024 4
20 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 3
13 Jun, 2024 8-K
9 May, 2024 10-Q
9 May, 2024 8-K
25 Apr, 2024 DEFA14A
25 Apr, 2024 DEF 14A
25 Apr, 2024 ARS
15 Apr, 2024 PRE 14A
5 Apr, 2024 SC 13G/A
29 Mar, 2024 SC 13D/A
29 Mar, 2024 SC 13D/A
29 Mar, 2024 4
28 Mar, 2024 8-K
28 Mar, 2024 4
28 Mar, 2024 SC 13D/A
28 Mar, 2024 SC 13D/A
26 Mar, 2024 424B5
25 Mar, 2024 8-K
21 Mar, 2024 10-K
21 Mar, 2024 8-K
5 Mar, 2024 4
5 Mar, 2024 4
4 Mar, 2024 144
1 Mar, 2024 144
1 Mar, 2024 144
14 Feb, 2024 4
12 Feb, 2024 144
9 Feb, 2024 SC 13D/A
7 Feb, 2024 SC 13G/A
31 Jan, 2024 SC 13G/A
18 Jan, 2024 4
18 Jan, 2024 4
18 Jan, 2024 4
18 Jan, 2024 4
18 Jan, 2024 4
18 Jan, 2024 SC 13G
8 Jan, 2024 8-K
8 Jan, 2024 4
8 Jan, 2024 4
8 Jan, 2024 4
8 Jan, 2024 4
8 Jan, 2024 4
8 Jan, 2024 4
3 Jan, 2024 S-8
13 Nov, 2023 SC 13G/A
9 Nov, 2023 8-K
9 Nov, 2023 10-Q
3 Nov, 2023 SC 13G
27 Oct, 2023 SC 13G
26 Oct, 2023 SC 13G
17 Oct, 2023 8-K
16 Oct, 2023 8-K
10 Oct, 2023 SC 13G/A
23 Aug, 2023 4
10 Aug, 2023 8-K
10 Aug, 2023 10-Q
5 Jul, 2023 4
5 Jul, 2023 4
5 Jul, 2023 8-K
5 Jul, 2023 3
27 Jun, 2023 8-K
26 Jun, 2023 8-K
22 Jun, 2023 4
22 Jun, 2023 4
22 Jun, 2023 4
22 Jun, 2023 4
22 Jun, 2023 4
22 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 8-K
9 Jun, 2023 4
9 Jun, 2023 4
9 Jun, 2023 4
11 May, 2023 10-Q
11 May, 2023 8-K
10 May, 2023 SC 13G/A
5 May, 2023 EFFECT
3 May, 2023 CORRESP
24 Apr, 2023 ARS
24 Apr, 2023 S-3/A
24 Apr, 2023 DEFA14A
24 Apr, 2023 DEF 14A
14 Apr, 2023 PRE 14A
30 Mar, 2023 8-K CEO Change
21 Mar, 2023 UPLOAD
17 Mar, 2023 S-3
16 Mar, 2023 10-K
16 Mar, 2023 8-K
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13D/A
10 Feb, 2023 SC 13G
10 Feb, 2023 SC 13G/A
9 Feb, 2023 SC 13G
3 Feb, 2023 SC 13G
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
10 Jan, 2023 3
9 Jan, 2023 8-K
9 Jan, 2023 S-8
5 Dec, 2022 8-K
2 Dec, 2022 8-K
9 Nov, 2022 10-Q
9 Nov, 2022 8-K
7 Oct, 2022 4
30 Sep, 2022 4
22 Sep, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
17 Aug, 2022 4
11 Aug, 2022 8-K
11 Aug, 2022 10-Q
10 Aug, 2022 4
10 Aug, 2022 4
26 Jul, 2022 4
26 Jul, 2022 4
18 Jul, 2022 4
21 Jun, 2022 4
21 Jun, 2022 4
21 Jun, 2022 4
21 Jun, 2022 4
21 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
7 Jun, 2022 4
3 Jun, 2022 SC 13D/A
16 May, 2022 8-K
13 May, 2022 SC 13D/A
12 May, 2022 8-K
12 May, 2022 10-Q
5 May, 2022 SC 13D/A
2 May, 2022 SC 13D/A
2 May, 2022 SC 13D/A
29 Apr, 2022 4
28 Apr, 2022 4
28 Apr, 2022 8-K
26 Apr, 2022 424B5
25 Apr, 2022 8-K
25 Apr, 2022 424B5
22 Apr, 2022 8-K
21 Apr, 2022 DEF 14A
21 Apr, 2022 DEFA14A
29 Mar, 2022 8-K
29 Mar, 2022 3
29 Mar, 2022 4
17 Mar, 2022 10-K
17 Mar, 2022 S-8
17 Mar, 2022 8-K
18 Feb, 2022 SC 13G
14 Feb, 2022 SC 13G/A
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
3 Dec, 2021 4
22 Nov, 2021 SC 13D/A
10 Nov, 2021 10-Q
10 Nov, 2021 8-K
22 Oct, 2021 8-K
7 Oct, 2021 8-K
1 Oct, 2021 4
3 Sep, 2021 424B5
2 Sep, 2021 4
2 Sep, 2021 EFFECT
31 Aug, 2021 CORRESP
18 Aug, 2021 UPLOAD
12 Aug, 2021 10-Q
12 Aug, 2021 8-K
12 Aug, 2021 S-3
9 Aug, 2021 4
4 Aug, 2021 4
14 Jul, 2021 8-K
12 Jul, 2021 SC 13G/A
6 Jul, 2021 4
23 Jun, 2021 4
17 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 8-K
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
4 Jun, 2021 4
13 May, 2021 8-K
13 May, 2021 10-Q
12 May, 2021 4
6 May, 2021 8-K
5 May, 2021 4
28 Apr, 2021 8-K
22 Apr, 2021 DEFA14A
22 Apr, 2021 DEF 14A
5 Apr, 2021 4
2 Apr, 2021 4
1 Apr, 2021 4
31 Mar, 2021 3
25 Mar, 2021 10-K
25 Mar, 2021 8-K
16 Feb, 2021 SC 13G/A
12 Feb, 2021 SC 13G/A
3 Feb, 2021 4
2 Feb, 2021 SC 13G
26 Jan, 2021 4
19 Jan, 2021 4
19 Jan, 2021 8-K
15 Jan, 2021 S-8
13 Jan, 2021 8-K
12 Jan, 2021 4
12 Jan, 2021 4
12 Jan, 2021 4
12 Jan, 2021 4
12 Jan, 2021 4
Last update:2025-03-06 12:32:55.271590

Sign Up to Subscribe